Cargando…
Current Management of Primary Immune Thrombocytopenia
Primary immune thrombocytopenia is an autoimmune disorder of unknown cause affecting both children and adults. The low peripheral blood platelet count is caused by premature platelet destruction by self-reacting antibodies in addition to an impairment of platelet production. The disease is heterogen...
Autores principales: | Provan, Drew, Newland, Adrian C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635183/ https://www.ncbi.nlm.nih.gov/pubmed/26499177 http://dx.doi.org/10.1007/s12325-015-0251-z |
Ejemplares similares
-
Current Concepts in the Diagnosis and Management of Adult Primary Immune Thrombocytopenia: Our Personal View
por: González-López, Tomás José, et al.
Publicado: (2023) -
Recent advances in the mechanisms and treatment of immune thrombocytopenia
por: Provan, Drew, et al.
Publicado: (2022) -
Long-Term Outcome of Otherwise Healthy Individuals with Incidentally Discovered Borderline Thrombocytopenia
por: Stasi, Roberto, et al.
Publicado: (2006) -
Proposal for a New Protocol for the Management of Immune Thrombocytopenia (ITP)
por: González-López, Tomás José, et al.
Publicado: (2022) -
Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry
por: Doobaree, Indraraj Umesh, et al.
Publicado: (2019)